Collectively, these results demonstrated that caffeine didn’t result in further growth inhibitory effects in RCC cells treated with G6PDH inhibitor and that G6PDH is a major target for caffeine for inhibition of RCC development and progression. Here, H6PD is linked to renal cell carcinoma.